Figure 2 Altered innate immune functions after sepsis

Slides:



Advertisements
Similar presentations
Cells of inflammation and Immunity G. Wharfe 2005.
Advertisements

Immune System Overview. GOT DEFENSE? ANATOMY OF THE IMMUNE SYSTEM The immune system is localized in several parts of the body –immune cells develop.
The Immune System Dr. Jena Hamra.
NAJRAN UNIVERSITY College of Medicine NAJRAN UNIVERSITY College of Medicine Microbiology &Immunology Course Lecture No. 15 Microbiology &Immunology Course.
Ch 43 The Body’s Defense. Three lines of Defense: 1. External defenses 2. Internal (phagocytes, inflammation) 3. Specific defense: (lymphocytes) 1 & 2.
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
INTRODUCTION TO THE IMMUNE SYSTEM
GENERAL IMMUNOLOGY PHT 324
Transplant rejection: T-helper cell paradigm
Avoiding Immune Detection
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Ch 43 The Body’s Defense.
Figure 1 Key elements of cancer-related inflammation
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Functional model of enthesitis
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Radiation-induced effects on tumour cells
Figure 2 Immune-escape mechanisms of CTCs in the peripheral blood
Figure 3 Altered adaptive immune functions after sepsis
Figure 1 Four nodes to target when inducing anti-tumour immunity
Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Main functions of IL-1
Figure 1 Immune mechanisms in liver homeostasis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Volume 61, Issue 6, Pages (June 2002)
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 TNFSF activities enhancing immune cell activation
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Malaria Vaccine Design: Immunological Considerations
Nat. Rev. Urol. doi: /nrurol
Figure 4 Macrophage-targeting antitumour treatment approaches
Nat. Rev. Urol. doi: /nrurol
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Figure 3 The mechanism of injury in ACLF
Figure 2 Emerging models of antibody-mediated rejection (ABMR) and
Figure 4 Macrophages in liver inflammation
Nat. Rev. Nephrol. doi: /nrneph
Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The role of CTLA4 and PD1 in T cell activation
Targets for immunotherapy of liver cancer
Figure 4 TNFSF inflammatory activities in tissue cells
Checkpoint blockade therapy resistance in Hodgkin's lymphoma
Figure 2 Effects of imatinib on components of the anticancer immunosurveillance system Figure 2 | Effects of imatinib on components of the anticancer immunosurveillance.
Mechanisms of immune escape in the tumor microenvironment.
Figure 3 Biologics that attenuate effector responses in the kidney
Figure 7 T cells in liver inflammation
Pro-endometriotic niche in endometriosis
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Figure 1 Principal pathogenic mechanisms of
Nat. Rev. Urol. doi: /nrurol
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Figure 3 Tumours secrete factors that cause systemic immunosuppression
Nat. Rev. Urol. doi: /nrurol
Deciphering and Reversing Tumor Immune Suppression
David C. Soler, Thomas S. McCormick 
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Role of chemokines in dendritic cell migration
Lec.9 Cytokines.
Figure 1 The role of macrophages in RA
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
Macrophage Classes and Roles in Immunity
IFNα Induces MDSC Maturation and Loss of Suppressive Function
Figure 1. Cross talk between the immune system and osteoclasts in osteoclastogenesis. Osteoclasts are derived from monocyte precursor cells. RANKL from.
Plasmacytoid Dendritic Cells in Melanoma: Can We Revert Bad into Good?
Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs  Darwin J. Prockop, Joo Youn Oh,
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Differential pathway regulation in advanced idiopathic pulmonary fibrosis (IPF) lung. a) Metacore analyses of pathway enrichment in IPF versus control.
Presentation transcript:

Figure 2 Altered innate immune functions after sepsis Figure 2 | Altered innate immune functions after sepsis. The innate immune response is altered after sepsis in patients and in mice. These immune alterations occur not only in the blood but also in the bone marrow and in organs that are distant from the initial site of infection. These alterations include increased release of immature neutrophils and myeloid-derived suppressor cells (MDSCs) from the bone marrow, which is also accompanied by alterations in the functions of mature neutrophils. The phenotype and functions of monocytes and/or macrophages and dendritic cells are also altered and include decreased effector functions, increased production of anti-inflammatory mediators and increased expression of immune checkpoint inhibitors. These alterations are deleterious for the host, as they result in a diminished first-line response against infection and decreased inflammation as well as altered T cell functions. HLA-DR, HLA class II histocompatibility DR; PD1, programmed cell death protein 1; PDL1, programmed cell death 1 ligand 1; PGE2, prostaglandin E2; TGFβ, transforming growth factor-β; TNF, tumour necrosis factor. Venet, F. & Monneret, G. (2017) Advances in the understanding and treatment of sepsis-induced immunosuppression Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.165